Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heterogeneous Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107098802B reveals a green Beta zeolite method for 2-alkylanthraquinone, offering superior catalyst stability and reduced waste for hydrogen peroxide intermediates.
Patent CN1812990A details a novel Pd/C catalyzed route for famciclovir, achieving superior purity by minimizing hydrolysis impurities through optimized solvent systems.
Patent CN1530171A discloses a robust heterogeneous catalyst system for producing high-ee hydroxy esters, enabling significant cost reduction in chiral synthesis manufacturing.
Patent CN112979658B reveals a green synthesis for flumazenil intermediates, eliminating toxic phosgene and improving yield for reliable pharmaceutical supply chains.
Patent CN114805031A reveals efficient aryl halide hydroxylation using recyclable CuPc catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN115739188B enables high-purity L-isopulegol via heterogeneous catalysis. Offers scalable supply chain solutions and cost reduction in synthetic flavors manufacturing.
Novel green synthesis of diphenyldiazene using zirconium hydroxide catalyst offers high yield and cost efficiency for pharmaceutical and fine chemical manufacturing supply chains.
Novel Cu/Nb2O5 catalyst enables efficient secondary amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel solid-acid catalyzed route for high-purity crosslinkers. Reduces equipment corrosion and simplifies purification for reliable supply chain partners.
Patent CN113336791A details a novel ZSM-5 supported catalyst method for Fosfomycin Calcium, offering higher yields and reduced heavy metal residues for antibiotic manufacturing.
Patent CN105327703A details a recyclable gold nanocatalyst for quinazoline synthesis. This method eliminates hazardous oxidants, offering safer supply chains and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN101580498B details a water-based Paal-Knorr reaction using cation exchange resin. This method offers significant cost reduction in pharmaceutical intermediate manufacturing and superior supply chain reliability.
Patent CN114805395B details a continuous synthesis of ACB-7 with high yield, avoiding toxic reagents. Ideal for reliable pharmaceutical intermediates supply chains.
Novel zinc-mediated reduction route for Roxadustat intermediates. High purity, scalable, and cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN111995635A details a green method for organosilicon synthesis using chitosan-supported copper nanoparticles in water, offering significant cost and supply chain advantages.
Patent CN108176392B reveals a composite catalyst for MDA production, eliminating caustic neutralization. Offers significant cost reduction and purity improvements for polyurethane precursors.
Patent CN112707919B introduces a graphene-supported copper catalyst for synthesizing 3-decarbamoyl cefuroxime acid, offering high purity and reduced phosphorus waste.
Patent CN114426508A reveals a novel one-pot synthesis for beta-carotene intermediates. Achieve >90% yield with simplified purification and reduced operational costs.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN112521348B details a green route for epoxysuccinic acid using titanium silicalite, eliminating heavy metals and reducing costs for water treatment and pharma sectors.